Designing before writing: the real AI opportunity in clinical trials

Faro CTO Patrick Leung sat down with CTO Uncovered to talk about why some of the most consequential decisions in medicine, like trial design and endpoint selection, still start out as prose in a Word document. Patrick walks through why he sees trial design, not authoring, as the layer where AI can create the most value, and why that kind of AI can only work on top of structured data rather than unstructured text. The conversation also covers his path from Google and Two Sigma into clinical development, how Faro keeps clinical experts in the loop on every AI output, and his broader thinking on where AI is headed across engineering and beyond.

Read the full profile on CTO Uncovered, here.